SIRT1 and relapsing-remitting multiple sclerosis: Interesting prospective studies [9,37] conducted in RRMS patients demonstrated a decrease in SIRT1 mRNA and phosphorylated SIRT1 expression in PBMCs during relapses, when compared to remissions.